|
|
|
|
Vir Biotechnology Inc (VIR) |
|
|
|
| |
VIR's Operating Income Growth by Quarter and Year
Vir Biotechnology Inc 's Operating Income results by quarter and year
|
Select the Comparisons :
|
|
Select the Ratio:
|
Operating Income Growth Y/Y▼
|
Operating Income Growth Y/Y▼
|
| VIR Operating Income (in millions $) |
FY 2022 |
FY 2021 |
FY 2020 |
FY 2019 |
| IV Quarter |
December |
-
|
571.75
|
-108.40
|
47.68
|
| III Quarter |
September |
194.96
|
-53.39
|
-87.62
|
-47.68
|
| II Quarter |
June |
-225.22
|
61.02
|
-29.05
|
0.00
|
| I Quarter |
March |
1,013.83
|
-158.63
|
-71.91
|
0.00
|
| FY |
|
983.57
|
420.75
|
-296.98
|
0.00
|
| VIR Operating Income third quarter 2022 Y/Y Growth Comment |
Vir Biotechnology Inc in the third quarter 2022 achieved Operating Income of $ 194.96 millions compare to Operating Loss recorded in same quarter a year ago.
Looking into third quarter 2022 results within Biotechnology & Pharmaceuticals industry 6 other companies have achieved higher Operating Income growth. While Vir Biotechnology Inc ' s Operating Income no change of % ranks overall at the positon no. 361 in the third quarter 2022.
Explain Operating Income growth
|
| VIR Operating Income ( Y/Y Growth %) |
2022
|
2021 |
2020 |
2019 |
| IV Quarter |
December |
- |
- |
- |
- |
| III Quarter |
September |
- |
- |
- |
- |
| II Quarter |
June |
- |
- |
- |
- |
| I Quarter |
March |
- |
- |
- |
- |
| FY |
|
- |
- |
- |
- |
VIR Operating Income (Quarter on Quarter Growth %) |
2022
|
2021 |
2020 |
2019 |
| IV Quarter |
December |
- |
- |
- |
- |
| III Quarter |
September |
- |
- |
- |
- |
| II Quarter |
June |
- |
- |
- |
- |
| I Quarter |
March |
77.32 % |
- |
- |
- |
| FY (Year on Year) |
|
- |
- |
- |
- |
| Operating Income Y/Y Growth Statistics |
| High |
Average |
Low |
| 278.66 % |
93.23 % |
-17.97 % |
| (Mar 31 2022) |
|
(Jun 30 2022) |
|
|
| Operating Income Y/Y Growth Statistics |
| High |
Average |
Low |
| 278.66 % |
93.23 % |
-17.97 % |
| (Mar 31 2022) |
|
(Jun 30 2022) |
|
| Operating Income by Quarter for the Fiscal Years 2019, 2020, 2021, 2022 |
Vir Biotechnology Inc 's Q/Q Operating Income Growth
| Operating Income Q/Q Growth Statistics |
| High |
Average |
Low |
| 77.32 % |
77.32 % |
77.32 % |
| (Mar 31 2022) |
|
|
| VIR's III. Quarter Q/Q Operating Income Comment |
This turnaround III. Quarter 2022where Vir Biotechnology Inc delivered Operating Income of $ 194.96 millions should be starting point of better business climet.Vir Biotechnology Inc announced in the III. Quarter 2022 Operating Income of $ 194.96 millions compare to Operating Loss recorded in previos quarter.
Within Biotechnology & Pharmaceuticals industry Vir Biotechnology Inc achieved highest sequential Operating Income growth. While Vir Biotechnology Inc 's Operating Income growth quarter on quarter, overall rank is 0. |
|
|
|
| Operating Income Q/Q Growth Statistics |
| High |
Average |
Low |
| 77.32 % |
77.32 % |
77.32 % |
| (Mar 31 2022) |
|
|
| VIR's III. Quarter Q/Q Operating Income Comment |
This reversal of fortune III. Quarter 2022where Vir Biotechnology Inc published Operating Income of $ 194.96 millions may be considered as a inception of improved performance.Vir Biotechnology Inc announced in the III. Quarter 2022 Operating Income of $ 194.96 millions compare to Operating Loss recorded in previos quarter.
Within Biotechnology & Pharmaceuticals industry Vir Biotechnology Inc achieved highest sequential Operating Income growth. While Vir Biotechnology Inc 's Operating Income growth quarter on quarter, overall rank is 0. |
|
Vir Biotechnology Inc 's 12 Months Operating Income Growth Year on Year
Operating Income TTM Growth |
12 Months Ending
(Sep 30 2022) |
12 Months Ending
(Jun 30 2022) |
12 Months Ending
(Mar 31 2022) |
12 Months Ending
(Dec 31 2021) |
12 Months Ending
(Sep 30 2021) |
| Cumulative Operating Income 12 Months Ending |
$ 1,555.32 |
$ 1,306.97 |
$ 1,593.21 |
$ 420.75 |
$ -259.41 |
| Y / Y Operating Income Growth (TTM) |
- |
- |
- |
- |
- |
| Year on Year Operating Income Growth Overall
Ranking |
| | |
